Results: 6

  • Agalsidase Alfa.

    Published in:
    BioDrugs, 2012, v. 26, n. 5, p. 335, doi. 10.2165/11209690-000000000-00000
    By:
    • Keating, Gillian M.
    Publication type:
    Article

  • Vemurafenib.

    Published in:
    BioDrugs, 2012, v. 26, n. 5, p. 325, doi. 10.2165/11209860-000000000-00000
    By:
    • Keating, Gillian M.
    Publication type:
    Article

  • Recombinant Human C1 Inhibitor (Conestat Alfa).

    Published in:
    BioDrugs, 2012, v. 26, n. 5, p. 315, doi. 10.2165/11206880-000000000-00000
    By:
    • Plosker, Greg L.
    Publication type:
    Article

  • Immunogenicity Assessment of Recombinant Human C1-Inhibitor.

    Published in:
    BioDrugs, 2012, v. 26, n. 5, p. 303, doi. 10.2165/11634370-000000000-00000
    By:
    • Hack, C. Erik;
    • Mannesse, Maurice;
    • Baboeram, Aartie;
    • Oortwijn, Beatrijs;
    • Relan, Anurag
    Publication type:
    Article

  • A Perspective on Bioactive Cell Microencapsulation.

    Published in:
    BioDrugs, 2012, v. 26, n. 5, p. 283, doi. 10.2165/11632640-000000000-00000
    By:
    • Acarregui, Argia;
    • Murua, Ainhoa;
    • Pedraz, José L.;
    • Orive, Gorka;
    • Hernández, Rosa M.
    Publication type:
    Article

  • Preclinical Cardiovascular Safety Evaluations of Biologics.

    Published in:
    BioDrugs, 2012, v. 26, n. 5, p. 275, doi. 10.2165/11633490-000000000-00000
    By:
    • Hondeghem, Luc;
    • De Clerck, Fred
    Publication type:
    Article